https://www.vorbio.com/publication/telitacicept-a-novel-horizon-in-targeting-autoimmunity-and-rheumatic-diseases/
Telitacicept: A novel horizon in targeting autoimmunity and rheumatic diseases | Vor Bio
Dec 18, 2025 - [...]Read More... from Telitacicept: A novel horizon in targeting autoimmunity and rheumatic diseases
rheumatic diseasestelitaciceptnovelhorizontargeting
https://www.massachusettshealthcarejournal.com/article/946069866-telitacicept-demonstrates-deep-and-durable-minimal-symptom-expression-through-48-weeks-in-generalized-myasthenia-gravis
Telitacicept Demonstrates Deep and Durable Minimal Symptom Expression Through 48 Weeks in...
telitaciceptdemonstratesdeepdurableminimal